Companies Use Blockchain To Connect Hemp Growers, Consumers
Source: Streetwise Reports  (10/19/22)
Industrial hemp is legal in all 50 states, and companies are working to get CBD, insulation, textiles, and biofuel made from it to the masses. These three companies hope their partnership will help connect the growers and buyers. More >

Steady News Stream Expected From Exploration Co.
Source: Adam Schatzker   (10/19/22)
With 13 active drill rigs at its project in Spain, this Canadian mining firm should continue announcing results over the near term, noted a Research Capital Corp. report. More >

Third-Party Firm Rates Hydrogen Boiler Nearly 100% Efficient
Source: Streetwise Reports  (10/17/22)
Jericho Energy Ventures is working to bring its zero-emission hydrogen boilers to companies for commercial heating, hot water, and industrial steam. More >

Analyst Calls Rare Earth Co.'s Property a 'Logistical Dream'
Source: Michael Gray  (10/15/22)
This Canadian critical metals firm with many "attractive attributes" is well-positioned to become a globally significant rare earth oxide producer, noted an Agentis Capital report. More >

Lumber Stocks Are Over Valued and Poised for a Plunge
Source: Ron Struthers  (10/15/22)
Markets will remain in a bear market for some time, and it is best to look for short trades. Lumber stocks ran up in price with high lumber prices and a post-Covid-19 recovery in the economy. They are priced too high and not reflecting lower lumber prices and a softer housing market induced by a coming recession. More >

Biotech Co.'s Target Price Over Three Times Current
Source: Dr. Joseph Pantginis   (10/13/22)
Expanded interim data from the Phase 2 trial of this biotech's lead asset PDS0101 in HPV16-associated cancers are consistent with previously reported results from the same study. Read more to discover why H.C Wainright & Co. believes this stock is a Buy with a target price over three times the current. More >

Silver Co. Posts Record Production in Q3; Raises FY Guidance
Source: Streetwise Reports  (10/13/22)
Shares of Gatos Silver Inc. traded 29% higher yesterday after the company reported it achieved record levels of production at its Cerro Los Gatos mine during Q3/22. The firm raised its FY/22 production guidance while lowering its operating cost estimates. More >

Biopharma Co. Partners With Merck for Combo Drug Trial
Source: Dr. Joseph Pantginis  (10/12/22)
With this and other clinical studies, the U.S. company has a busy and, thus, catalyst-rich Q4/22 ahead, noted an H.C. Wainwright & Co. report. More >

Rare Earths Co. Sees Big Results at British Columbia Project
Source: Streetwise Reports  (10/12/22)
Defense Metals Corp. is seeing more high-grade results from assays at its Wicheeda rare earth element deposit in British Columbia. Results from three holes, including one released on Thursday, are showing broad mineralization. More >

Biopharma Co.'s Shares Roll to New 52-Week High Price
Source: Streetwise Reports  (10/12/22)
Shares of DICE Therapeutics Inc. traded 62% higher yesterday and established a new 52-week intraday high after the company reported positive topline data from its Phase 1 DC-806 Psoriasis study. More >

Lithium Co. Drills 'Another World Class Hit'
Source: Katie Lachapelle   (10/12/22)
New results from the Ontario lithium deposit show high grades and significant widths, noted a Canaccord Genuity report. More >

Chen Reveals His Picks for Last Quarter
Source: Streetwise Reports  (10/11/22)
Asset manager Chen Lin's picks for the home stretch of 2022 include several biotechs and some precious metals companies. More >

Wall Street Hemophilia
Source: Michael Ballanger  (10/11/22)
Expert Michael Ballanger of GGM Advisory reviews the current stock market, the outlook for gold, and how he believes everyone should move forward. More >

Metamaterials Co. Works To Safeguard Cash From Counterfeiters
Source: Streetwise Reports  (10/7/22)
This nanotech company has been awarded US$4.3 million to develop anti-counterfeiting measures on currency for a confidential G10 central bank customer. More >

US Firm Teams up With Leading Pharma Co. To Delay T1D Onset
Source: Streetwise Reports  (10/7/22)
Provention Bio Inc.'s shares traded 25% higher yesterday after the company reported it is joining forces with Sanofi U.S. to support the potential upcoming U.S. launch of its teplizumab for use in delaying the onset of clinical type 1 diabetes in at-risk patients. The U.S. FDA is expected to rule on the firm's Biologics License Application in mid-November 2022. More >

Expert Shares Three Stocks He Believes Are of 'Great Value'
Source: Ron Struthers  (10/7/22)
Expert Ron Struthers believes TC Energy is a well-run pipeline company as it is yielding about 6.5% and has increased its dividend every year since the turn of the century. He also discusses how oil tanker rates are soaring as the market tightens more with the Ukraine war, but DHT Holdings is a laggard worth a look. More >

Explorer Raises CA$3M To Advance Nevada Gold Project
Source: Streetwise Reports  (10/6/22)
Vancouver mineral explorer Zacapa Resources Ltd. is preparing to close on a CA$3 million private placement and has proactively taken steps to separate and possibly spin out its copper assets from its core gold property holdings that include its cornerstone South Bullfrog project located near the rapidly emerging Beatty gold district in Nevada. More >

Analyst Calls Romanera Project 'A Mine in the Making'
Source: Streetwise Reports  (10/6/22)
Friday, Emerita Resources Corp. announced drill results for its fully-permitted La Romanera deposit at its 100%-owned Iberian Belt West project. Read to discover the latest results and why President Joaquin Merino is continuing to accelerate its Romanera drill program. More >

Silver Explorer's Shares Rise After News of New Investor Breaks
Source: Streetwise Reports  (10/6/22)
Dolly Varden Silver Corp. is adding a new institutional investor to its stable of big-name backers that includes Hecla Mining Co. and mining financier Eric Sprott. More >

Biopharma Target Price 10 Times Current
Source: Dr. Elemer Piros  (10/6/22)
Read to learn why ROTH Capital Partners gave Atai Life Sciences NV a Buy rating and a target price 10 times its current. More >

Biotech Co.'s Drug Showing 'Early Signs of Benefit'
Source: Dr. Elemer Piros  (10/6/22)
With this upcoming analysis, the board will determine whether the Phase 2b/3 trial may continue to completion, noted a ROTH Capital Partners report. More >

Trial Results of New Drug for An Eye Disease 'Encouraging'
Source: Dr. Yale Jen  (10/6/22)
The data suggest this treatment could be safer and more effective in treating proliferative vitreoretinopathy than compounded methotrexate, noted a Laidlaw & Co. report. More >

Resource Could Reach 42.5 Mt, Analyst Says
Source: Adam Schatzker  (10/5/22)
Deposit upside at this polymetallic project in Spain is indicated by the historical mineral resource and past and current drill results, noted a Research Capital Corp. report. More >

Gold Junior Looks To Expand Resources at Nevada Project
Source: Streetwise Reports  (10/4/22)
Drilling is underway at this company’s project in northern Nevada, where it hopes to expand its resources with help from a major. More >

B.C. Mine on Verge of Producing Gold
Source: Bill Newman  (10/4/22)
Placer gold recovery at this project is expected to start in the coming months after mine stabilization is completed, noted a Research Capital Corp. report. More >